Literature DB >> 26479977

Pulmonary hypertension associated with bronchiolitis obliterans after hematopoietic stem cell transplantation.

A Pate1, S Rotz1, M Warren2, R Hirsch3, M Cash3, K C Myers1, J El-Bietar1, A Nelson1, G Wallace1, A H Filipovich1, J Bleesing1, R S Chima4, S M Davies1, S Jodele1, C E Dandoy1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26479977      PMCID： PMC4740209          DOI： 10.1038/bmt.2015.248

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  15 in total

Review 1.  Pulmonary hypertension after hematopoietic stem cell transplantation.

Authors:  Christopher E Dandoy; Russel Hirsch; Ranjit Chima; Stella M Davies; Sonata Jodele
Journal:  Biol Blood Marrow Transplant       Date:  2013-07-23       Impact factor: 5.742

2.  Outcome and treatment of late-onset noninfectious pulmonary complications after allogeneic haematopoietic SCT.

Authors:  K Ueda; T Watadani; E Maeda; S Ota; K Kataoka; S Seo; K Kumano; A Hangaishi; T Takahashi; Y Imai; K Ohtomo; M Fukayama; Y Nannya; M Kurokawa
Journal:  Bone Marrow Transplant       Date:  2010-03-08       Impact factor: 5.483

3.  Bronchiolitis obliterans after allogeneic hematopoietic SCT: further insight--new perspectives?

Authors:  M Ditschkowski; A H Elmaagacli; M Koldehoff; T Gromke; R Trenschel; D W Beelen
Journal:  Bone Marrow Transplant       Date:  2013-02-25       Impact factor: 5.483

Review 4.  Obliterative bronchiolitis.

Authors:  Alan F Barker; Anne Bergeron; William N Rom; Marshall I Hertz
Journal:  N Engl J Med       Date:  2014-05-08       Impact factor: 91.245

Review 5.  Echocardiography in pulmonary arterial hypertension: from diagnosis to prognosis.

Authors:  Eduardo Bossone; Antonello D'Andrea; Michele D'Alto; Rodolfo Citro; Paola Argiento; Francesco Ferrara; Antonio Cittadini; Melvyn Rubenfire; Robert Naeije
Journal:  J Am Soc Echocardiogr       Date:  2012-11-08       Impact factor: 5.251

6.  High-dose corticosteroid therapy for bronchiolitis obliterans after bone marrow transplantation in children.

Authors:  F Ratjen; O Rjabko; B Kremens
Journal:  Bone Marrow Transplant       Date:  2005-07       Impact factor: 5.483

Review 7.  Noninvasive imaging of pulmonary hypertension.

Authors:  Karl-Friedrich Kreitner
Journal:  Semin Respir Crit Care Med       Date:  2014-01-30       Impact factor: 3.119

8.  Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT).

Authors:  Nazzareno Galiè; Marius M Hoeper; Marc Humbert; Adam Torbicki; Jean-Luc Vachiery; Joan Albert Barbera; Maurice Beghetti; Paul Corris; Sean Gaine; J Simon Gibbs; Miguel Angel Gomez-Sanchez; Guillaume Jondeau; Walter Klepetko; Christian Opitz; Andrew Peacock; Lewis Rubin; Michael Zellweger; Gerald Simonneau
Journal:  Eur Heart J       Date:  2009-08-27       Impact factor: 29.983

9.  Pulmonary hypertension in patients with bronchiolitis obliterans syndrome listed for retransplantation.

Authors:  S D Nathan; O A Shlobin; S Ahmad; S D Barnett; N A Burton; M T Gladwin; R F Machado
Journal:  Am J Transplant       Date:  2008-07       Impact factor: 8.086

10.  Septal curvature is marker of hemodynamic, anatomical, and electromechanical ventricular interdependence in patients with pulmonary arterial hypertension.

Authors:  Francois Haddad; Julien Guihaire; Mehdi Skhiri; Andre Y Denault; Olaf Mercier; Shadi Al-Halabi; Bojan Vrtovec; Elie Fadel; Roham T Zamanian; Ingela Schnittger
Journal:  Echocardiography       Date:  2013-12-23       Impact factor: 1.724
View more
  1 in total

Review 1.  Myeloid-Derived Suppressor Cells and Pulmonary Hypertension.

Authors:  Andrew J Bryant; Borna Mehrad; Todd M Brusko; James D West; Lyle L Moldawer
Journal:  Int J Mol Sci       Date:  2018-08-03       Impact factor: 5.923
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.